A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke.
Phase of Trial: Phase IV
Latest Information Update: 06 Jul 2011
At a glance
- Drugs Brain extract (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Acronyms CASTA
- Sponsors Ebewe
- 06 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Dec 2010 Planned end date changed from 1 May 2010 to 1 Feb 2011 as reported by ClinicalTrials.gov.
- 30 Sep 2009 Actual patient number (1071) added as reported by ClinicalTrials.gov.